Add to favorite
 
123
Subscribe to our Newsletters Subscribe to our Newsletters Get Daily Updates RSS


Clinical Trials of Insulin in Russia are Probably Fake
November 10, 2010 23:24


Former top manager of MannKind, an American biotechnological company, sues his employers for falsifying results of clinical trials of their anti-diabetes drug in Russia. Diabetes is a group of metabolic problems, due to which human body doesn't produce enough insulin to control blood sugar (Type I), or organism's cells do not adequately react to insulin produced (Type II).

Biotechnologists of MannKind company have been performing clinical trials of their new diabetes treatment in the Russian Federation and at the same time have negotiated with Moscow government about further cooperation. John Arditi, former senior director for regulatory affairs of MannKind company, accuses the company in misreporting results, obtained during testing the newest anti-diabetes treatment in our country.

Mr. Arditi's lawsuit is related to "Afrezza", insulin for inhalations. Insulin is a substance, which helps those, suffering from diabetes, control sugar content in their blood. "Afrezza"'s reported benefit is that patients with diabetes do not receive insulin with injections, but simply inhale it; insulin dissolves in patient's lungs and enters his blood stream. The inhaler is as small as palm of a hand. The drug, useful for patients with both types of diabetes is currently reviewed by FDA (Food and Drug Administration, USA).

 

 


Structure of insulin
The lawsuit, claiming clinical trials "scientifically negligent", is based upon several facts, one of which is same blood pressure in all Russian patients, who have participated in the trials, during several months of the trials. Mr. Arditi, who lost his job soon after he told FDA about suspicious trials, suggests the trials could have been based upon fictitious patients. However, MannKind biotechnological company denies everything and claims that independent experts didn't find anything wrong in the trial procedure and results.

Experts believe that John Arditi's lawsuit may be a serious problem for approval of insulin inhaler by FDA. The lawsuit has already caused a significant drop of MannKind’s shares. Former head of the Moscow government has met the head of MannKind's CEO Alfred Mann last year – the discussion between the two businessmen was dedicated to possible cooperation with the capital's health and biotechnological establishments in the field of treating diabetes, a serious and dangerous disease.

However, some experts think that insulin inhalations aren't a perfect solution for patients with diabetes. Delicate cells of alveolus aren't suitable for delivering insulin into blood stream, they say, because lungs were designed for dealing with gases. Insulin injections nowadays are almost painless, because insulin is injected with tiny and very sharp needles. Sometimes insulin is sold inside a syringe, which is very convenient, since you don't have to do anything with ampoules. Sometimes patients take insulin for tens of years, and consequences of a long-term inhaling of insulin are not studied enough, medical experts say.

Source: Gazeta.ru

Kizilova Anna


Tags: Russian scientists Russian science health Russian medicine  

Next Previous

You might also find interesting:

Russias Space Ambitions Beware of Icicles Media: Roscosmos to 3D-Print Live Tissues at ISS Rosneft to Experiment on Changing Trajectory of Drifting Icebergs Whats that Smell?









Comment on our site


RSS   twitter      submit



TAGS:
adventure tourism Russia  All-Russian Exhibition Centre  Russia Travel Tips  Novosibirsk  MYSTERIA Festival  Kirill Serebrennikov  terrorism  Russian cities  Exhibitions in Moscow  Ural   Kurchatovsky Institute  Russian toy stores  TNK-BP  Sochi  Russian scientists  LGBT in Russia  Sotsrealism  Bolshoi Theatre  Kizhi  Russian fashion designer  activity holidays  human rights  Russian science  Russian Cinema  Fashion  Oleg Anofriyev  Sergei Chekhonin  Kir Bulychev  Krasnodar region  Russian business  Central Bank of Russia  train tickets  Russian economy  Odnoklassniki  Sculpture  Amur Region  Semen Dezhnev  censorship in Russia  Arsenyev  Mercedes-Benz Fashion Week Russia  Moscow  Zyuratkul National Park  St. Petersburg Parks   Asteroids  Russian ballet dancers  Russian Music Instruments  St. Petersburg  Archeology  Russian tourism  Soviet Music 


Travel Blogs
Top Traveling Sites